开发治疗恰加斯病的新药和工具的迫切需求。 - Suppr

Suppr

超能文献

The urgent need to develop new drugs and tools for the treatment of Chagas disease.

作者信息

Muñoz Maria J, Murcia Laura, Segovia Manuel

出版信息

Expert Rev Anti Infect Ther. 2011 Jan;9(1):5-7. doi: 10.1586/eri.10.144.

DOI:10.1586/eri.10.144

PMID:21171870

Abstract

摘要

相似文献

The urgent need to develop new drugs and tools for the treatment of Chagas disease.

Expert Rev Anti Infect Ther. 2011 Jan;9(1):5-7. doi: 10.1586/eri.10.144.

Trypanosoma cruzi: a novel chemical class (nitrobenzofurans) active against infections of mice (Mus musculus).

Exp Parasitol. 1998 Jun;89(2):251-6. doi: 10.1006/expr.1998.4288.

Trypanocidal drugs: mechanisms, resistance and new targets.

Expert Rev Mol Med. 2009 Oct 29;11:e31. doi: 10.1017/S1462399409001252.

5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.

Eur J Med Chem. 2009 Oct;44(10):3909-14. doi: 10.1016/j.ejmech.2009.04.015. Epub 2009 Apr 14.

[Treatment of Chagas' disease].

Rev Med Chil. 1985 Feb;113(2):162-6.

Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.

Antimicrob Agents Chemother. 2005 Apr;49(4):1556-60. doi: 10.1128/AAC.49.4.1556-1560.2005.

[The chemotherapy of Chagas disease].

Medicina (B Aires). 1999;59 Suppl 2:147-65.

[Nifurtimox, a bright future for treatment of Chagas disease].

Med Trop (Mars). 2011 Apr;71(2):131-3.

Potential new clinical therapies for Chagas disease.

Expert Rev Clin Pharmacol. 2014 May;7(3):317-25. doi: 10.1586/17512433.2014.909282. Epub 2014 Apr 9.

Parasitology. Drugs to combat tropical protozoan parasites.

Science. 2002 Jul 19;297(5580):343-4. doi: 10.1126/science.1073126.

引用本文的文献

Venturicidin A affects the mitochondrial membrane potential and induces kDNA loss in .

Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0167123. doi: 10.1128/aac.01671-23. Epub 2024 Jun 13.

Monotherapy and combination chemotherapy for Chagas disease treatment: a systematic review of clinical efficacy and safety based on randomized controlled trials.

Parasitology. 2022 Nov;149(13):1679-1694. doi: 10.1017/S0031182022001081. Epub 2022 Aug 12.

Ravuconazole self-emulsifying delivery system: in vitro activity against amastigotes and in vivo toxicity.

Int J Nanomedicine. 2017 May 17;12:3785-3799. doi: 10.2147/IJN.S133708. eCollection 2017.

Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.

Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1819-1827. doi: 10.1007/s10096-016-2733-6. Epub 2016 Aug 4.

Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.

Antimicrob Agents Chemother. 2016 May 23;60(6):3355-64. doi: 10.1128/AAC.00343-16. Print 2016 Jun.

Aptamer based, non-PCR, non-serological detection of Chagas disease biomarkers in Trypanosoma cruzi infected mice.

PLoS Negl Trop Dis. 2014 Jan 16;8(1):e2650. doi: 10.1371/journal.pntd.0002650. eCollection 2014.

Challenges and perspectives of Chagas disease: a review.

J Venom Anim Toxins Incl Trop Dis. 2013 Dec 19;19(1):34. doi: 10.1186/1678-9199-19-34.

Clinical aspects of Chagas disease and implications for novel therapies.

Drug Dev Res. 2011 Sep;72(6):471-479. doi: 10.1002/ddr.20454.

Trypanosoma cruzi trans-sialidase in complex with a neutralizing antibody: structure/function studies towards the rational design of inhibitors.

PLoS Pathog. 2012 Jan;8(1):e1002474. doi: 10.1371/journal.ppat.1002474. Epub 2012 Jan 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验